Sumitomo Dainippon, JCR Pharmaceuticals deal

The companies will jointly conduct research using JCR’s J-Brain Cargo blood-brain barrier penetration technology and Sumitomo’s undisclosed psychiatry and neurology compounds. The companies declined t...